What is the active ingredient in mimosa hostilis for wound healing?

The primary active compounds are tannins (up to 16%) and flavonoids that stimulate collagen synthesis and inhibit collagen-degrading enzymes. These polyphenolic compounds promote fibroblast proliferation and accelerate tissue regeneration.

How much mimosa hostilis extract was used in clinical studies?

The successful clinical trial used a 5% Mimosa tenuiflora hydrogel applied topically to venous leg ulcers twice daily. No standardized oral dosages exist due to limited human studies and legal concerns regarding DMT content.

Is mimosa hostilis legal to buy as a supplement?

Legal status varies by jurisdiction due to natural DMT content in the bark. Topical preparations may be legal in some areas, but oral supplements containing bark extracts are restricted in countries where DMT is controlled.

Can mimosa hostilis help with inflammation besides wound healing?

Preclinical studies show reductions in inflammatory cytokines TNF-α and IL-6 in mouse models. However, human studies on systemic anti-inflammatory effects are lacking, and evidence remains limited to topical wound applications.

What are the side effects of mimosa hostilis supplements?

Topical use shows minimal side effects in clinical trials. Oral consumption may cause nausea, vomiting, and gastrointestinal distress. The DMT content poses risks of psychoactive effects and potential interactions with psychiatric medications.

What is the most effective form of mimosa hostilis for wound healing?

Clinical evidence supports topical hydrogel formulations of mimosa hostilis, with a 5% hydrogel demonstrating a 92% mean reduction in venous leg ulcers in a double-blind RCT. Topical application allows direct contact with affected tissue, making it more effective for dermal wounds than oral supplements. The hydrogel format enhances bioavailability and sustained release of the active compounds to the wound site.

Does mimosa hostilis interact with common wound care medications or antibiotics?

While mimosa hostilis has demonstrated antimicrobial properties in preclinical studies, there is limited clinical data on specific drug interactions with topical or oral antibiotics. If using mimosa hostilis supplements alongside prescription medications, consult a healthcare provider to assess potential interactions, particularly with immune-modulating or anti-inflammatory medications. The antimicrobial activity suggests potential synergy with certain treatments, but interaction studies are lacking.

Who benefits most from mimosa hostilis supplementation for skin and wound health?

Individuals with chronic venous leg ulcers or slow-healing wounds appear to benefit most, based on clinical trial evidence showing significant healing improvements. Those seeking natural antimicrobial and antioxidant support for skin health may also benefit from its traditional use profile. People with inflammatory skin conditions may see additional benefits due to preclinical evidence of reduced proinflammatory cytokine activity, though more human studies are needed to confirm these applications.

Mimosa Hostilis (Mimosa tenuiflora)

Mimosa hostilis (Mimosa tenuiflora) contains high concentrations of tannins and flavonoids that promote wound healing through collagen synthesis stimulation. Clinical research demonstrates significant efficacy in treating venous leg ulcers and chronic wounds.

Category: Amazonian Evidence: 2/10 Tier: Moderate

Mimosa Hostilis (Mimosa tenuiflora) — Hermetica Encyclopedia

Origin & History

Mimosa tenuiflora, also known as tepescohuite or jurema-preta, is a perennial tree native to northeastern Brazil and southern Mexico. It belongs to the Fabaceae family, with extracts typically obtained from the inner bark via aqueous or ethanolic methods.

Historical & Cultural Context

Traditionally used in Mexican medicine for wound healing, particularly burns and ulcers, Mimosa tenuiflora has been applied as a decoction or powder. In Brazilian folk medicine, it is used for conditions like bronchitis and inflammation.

Health Benefits

• Wound healing: A double-blind RCT showed a 92% mean reduction in venous leg ulcers using a 5% Mimosa tenuiflora hydrogel (PMID: 17088036).
• Anti-inflammatory effects: Preclinical studies indicate reductions in proinflammatory cytokines in mouse models [6].
• Antimicrobial properties: Traditional uses suggest antimicrobial benefits, supported by preclinical data [4].
• Antioxidant activities: Polyphenolic content suggests antioxidant potential [4].
• Safe topical application: Clinical trials report no significant side effects in topical use [1][2].

How It Works

Mimosa hostilis exerts therapeutic effects through tannins and flavonoids that stimulate fibroblast proliferation and collagen synthesis. These compounds inhibit matrix metalloproteinases (MMPs) that break down collagen, while promoting angiogenesis through VEGF pathway activation. The antimicrobial effects result from tannin-mediated bacterial cell wall disruption.

Scientific Research

Two double-blind, placebo-controlled RCTs tested a 5% Mimosa tenuiflora hydrogel for venous leg ulcers, showing significant improvement in one study (PMID: 17088036) but no significant difference in a follow-up study due to limitations including sample size [1][2]. No meta-analyses or additional RCTs for other indications are available.

Clinical Summary

A double-blind randomized controlled trial (n=62) demonstrated 92% mean reduction in venous leg ulcer size using 5% Mimosa tenuiflora hydrogel over 6 weeks. Preclinical studies in mouse models show significant reductions in TNF-α and IL-6 inflammatory markers. However, human clinical data remains limited to wound healing applications, with no studies on oral supplementation. Most evidence derives from traditional use and in vitro antimicrobial testing.

Nutritional Profile

Mimosa tenuiflora (Mimosa hostilis) root bark and aerial parts contain a distinct phytochemical profile rather than a conventional macronutrient profile, as it is used medicinally rather than as a dietary staple. Bioactive compounds are the primary focus of nutritional/biochemical interest: Tannins (primary active constituents) are present at approximately 16–19% dry weight in the root bark, predominantly condensed tannins (proanthocyanidins) including catechin and epicatechin oligomers, which are responsible for wound-healing and antimicrobial properties. Saponins are present at approximately 0.5–1.2% dry weight, contributing to anti-inflammatory and surfactant activity. Alkaloids include trace amounts of N,N-dimethyltryptamine (DMT) reported in root bark at roughly 0.31–0.57% dry weight, though concentrations vary significantly by region and preparation. Flavonoids identified include quercetin, kaempferol, and luteolin glycosides at combined concentrations of approximately 1–3% dry weight. Phenolic acids include gallic acid and ellagic acid derivatives. Fiber content in dried bark is substantial (estimated 20–35% as structural lignocellulose), though bioavailability as dietary fiber is negligible given its non-food application. Mineral content includes calcium (~800–1,200 mg/100g dry bark), potassium (~400–600 mg/100g), magnesium (~150–250 mg/100g), and trace iron and zinc. Crude protein is approximately 8–12% dry weight in leaf fractions, with limited data for bark. Bioavailability note: Tannins may reduce bioavailability of co-administered minerals and proteins due to binding affinity; topical application (as in wound-healing studies) bypasses gastrointestinal bioavailability concerns entirely.

Preparation & Dosage

Clinically studied dosage for topical application is a 5% crude cortex extract hydrogel, standardized to 1.8% tannins, applied daily for 8-13 weeks. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Calendula, Aloe Vera, Tea Tree Oil, Arnica, Manuka Honey

Safety & Interactions

Mimosa hostilis bark contains DMT (N,N-dimethyltryptamine), a Schedule I controlled substance in many countries when extracted. Topical preparations appear well-tolerated with minimal adverse effects reported in clinical trials. Oral consumption may cause gastrointestinal upset and should be avoided due to psychoactive compound content. Safety during pregnancy and lactation is unknown, and potential interactions with MAO inhibitors exist.